Activation by tyrosine phosphorylation as a prerequisite for protein kinase Cζ to mediate epidermal growth factor receptor signaling to ERK

Molecular Cancer Research

Volumn 8, Issue 5, 2010, Pages 783-797

  Valkova, Christina ^a,b   Mertens, Carmen ^a   Weisheit, Simona ^a   Imhof, Diana ^a   Liebmann, Claus ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C ZETA; TYROSINE; EGFR PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; BREAST CARCINOGENESIS; CATALYSIS; EMBRYO CELL; FIBROBLAST; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYMOLOGY; GENETICS; HEAD AND NECK TUMOR; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CATALYTIC DOMAIN; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; HEAD AND NECK NEOPLASMS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TYROSINE;

EID: 77952900961     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0164     Document Type: Article

References (44)

1. Hynes NE, Lane HA. ErbB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005;5:341-354
2. Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A, Paradiso A. The complexity of targeting EGFR signalling in cancer: from expression to turnover. Biochim Biophys Acta 2006;1766:20-139.
3. Normanno N, DeLuca A, Bianco C, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006;366:2-16.
4. Choong NW, Cohen EEW. Epidermal growth factor receptor directed therapy in head and neck cancer. Crit Rev Oncol Hematol 2006;57:25-43.
5. Tsang DK, Crowe DL. The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines. Int J Oncol 1999;15:519-523
6. Thomas SM, Coppelli FM, Wells A, et al. Epidermal growth factor receptor-stimulated activation of phospholipase Cγ-1 promotes invasion of head and neck squamous cell carcinoma. Cancer Res 2003;63:5629-5635
7. Gupta AK, McKenna WG, Weber CN, et al. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res 2002;8:885-892
8. Rogers SJ, Box C, Harrington KJ, Nutting C, Rhys-Evans P, Eccles SA. The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck. Expert Opin Ther Targets 2005;9:769-790
9. Song JI, Grandis JR. STAT signaling in head and neck cancer. Oncogene 2000;19:2489-2495
10. Xi S, Zhang Q, Gooding WE, Smithgall TE, Grandis JR. Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Cancer Res 2003;63:6763-6771
11. Cohen EE, Lingen MW, Zhu B, et al. Protein kinase Cζ mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res 2006;66:6296-6303
12. Berra E, Diaz-Meco MT, Lozano J, et al. Evidence for a role of MEK and MAPK during signal transduction by protein kinase Cζ. EMBO J 1995;14:6157-6163
13. Schönwasser CD, Marais RM, Marshall CJ, Parker PJ. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 1998;18:790-798
14. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular response. FASEB J 1995;9:484-496
15. Hirai T, Chida K. Protein kinase Cζ (PKCζ): activation mechanisms and cellular functions. J Biochem 2003;133:1-7.
16. Chou MM, Hou W, Johnson J, et al. Regulation of protein kinase Cζ by PI 3-kinase and PDK-1. Curr Biol 1998;8:1069-1077
17. Le Good JA, Brindley DN. Molecular mechanisms regulating protein kinase Cζ turnover and cellular transformation. Biochem J 2004;378:83-92.
18. Kim JH, Ohba M, Suh PG, Ryu SH. Novel functions of the phospholipase D2-Phox homology domain in protein kinase Cζ activation. Mol Cell Biol 2005;25:3194-3208
19. Steinberg SF. Distinctive activation mechanisms and functions for protein kinase Cδ. Biochem J 2004;384:449-459
20. Grunicke HH, Spitaler M, Mwanhewe J, Schwaiger W, Jenny M, Ueberall F. Regulation of cell survival by atypical protein kinase C isozymes. Adv Enzyme Regul 2003;43:213-228 (Pubitemid 36872833)
21. Ranganathan S, Wang Y, Kern FG, Qu Z, Li R. Activation loop phosphorylation-independent kinase activity of human protein kinase Cζ. Proteins 2007;67:709-719
22. LaVallie ER, Chockalingam PS, Collins-Racie LA, et al. Protein kinase Cζ is up-regulated in osteoarthritic cartilage and is required for activation of NF-κB by tumor necrosis factor and interleukin-1 in articular chondrocytes. J Biol Chem 2006;281:24124-24137
23. Park JW, Kim HP, Lee SJ, et al. Protein kinase C α and ζ differentially regulate death-inducing signaling complex formation in cigarette smoke extract-induced apoptosis. J Immunol 2008;180:4668-4678
24. Mao M, Fang X, LaPushin R, Bast RC, Mills GB. Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells. Biochem J 2000;352:475-482
25. Sun R, Gao P, Chen L, Ma D, Wang J, Oppenheim JJ, Zhang N. Protein kinase Cζ is required for epidermal growth factor-induced chemotaxis of human cancer cells. Cancer Res 2005;65:1433-1441
26. Xin M, Gao F, May WS, Flagg T, Deng X. Protein kinase Cζ abrogates the proapoptotic function of Bax through phosphorylation. J Biol Chem 2007;282:21268-21277
27. Adomeit A, Graness A, Gross S, Seedorf K, Wetzker R, Liebmann C. Bradykinin B2 receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Mol Cell Biol 1999;19:5289-5297
28. Imhof D, Nothmann D, Zoda MS, et al. Synthesis of linear and cyclic phosphopeptides as ligands for the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1. J Pept Sci 2005;11:390-400. (Pubitemid 40959939)
29. Cenni V, Döppler H, Sonnenburg ED, Maraldi N, Newton A, Toker A. Regulation of novel protein kinase C by phosphorylation. Biochem J 2002;363:537-545
30. Moasser MM, Basso P, Averbuch SD, Rosen N. The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer Res 2001;61:7184-7188
31. Garrett TP, McKern NM, Lou M, et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α. Cell 2002;110:763-773
32. Konishi H, Tanaka M, Takemura Y, et al. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci U S A 1997;94:1233-11237.
33. Leitges M, Sanz L, Martin P, et al. Targeted disruption of the ζPKC gene results in the impairment of the NF-κB pathway. Mol Cell 2001;8:771-780
34. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 1999;274:8335-8343
35. Liu Y, Wang B, Wang J, Wan W, Sun R, Zhao Y, Zhang N. Down-regulation of PKCζ expression inhibits chemotaxis signal transduction in human lung cancer cells. Lung Cancer 2009;63:210-218
36. Wan W, Zou H, Sun R, Liu Y, Wang J, Ma D, Zhang N. Investigate the role of PTEN in chemotaxis of human breast cancer cells. Cell Signal 2007;19:2227-2236
37. Wang J, Wan W, Sun R, et al. Reduction of Akt2 expression inhibits chemotaxis signal transduction in human breast cancer cells. Cell Signal 2008;20:1025-1034
38. Wooten MW, Vandenplas ML, Seibenhener ML, Geetha T, Diaz-Meco MT. Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway. Mol Cell Biol 2001;21:8414-8427
39. Songyang Z, Shoelson SE, Chaudhuri M, et al. SH2 domains recognize specific phosphopeptide sequences. Cell 1993;72:767-778
40. Kloth MT, Laughlin KK, Biscardi JS, Boerner JL, Parsons SJ, Silva CM. STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor. J Biol Chem 2003;278:1671-1679
41. Boerner JL, Demory ML, Silva C, Parsons SJ. Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol Cell Biol 2004;24:7059-7071
42. Valkova C, Maerz S, Imhof D, Liebmann C. Protein kinase Cε may act as EGF-inducible scaffold protein for phospholipase Cγ1. Cell Signal 2007;19:1830-1843
43. Moscat J, Diaz-Meco MT, Albert A, Campuzano S. Cell signaling and function organized by PB1 domain interactions. Mol Cell 2006;23:631-640
44. Yaffe M. Phosphotyrosine-binding domains in signal transduction. Mol Cell Biol 2002;3:177-186